Fed Study of Mylan Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan nitrofurantoin
monohydrate/macrocrystals capsules to Procter & Gamble Macrobid® capsules following a single,
oral 100 mg (1 x 100 mg) dose under fed conditions.